Patent · US Active

Anti-pro/latent-myostatin antibodies and uses thereof

US10307480B2 · kind B2 · utility

9Cited by
2References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 6, 2015
Grant dateJun 4, 2019
Priority date—
Expiry dateNov 6, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Aspects of the present disclosure relate to antibodies that specifically bind proMyostatin and/or latent Myostatin and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.